A citation-based method for searching scientific literature

Carmelo Gurnari, Emiliano Fabiani, Giulia Falconi, Serena Travaglini, Tiziana Ottone, Antonio Cristiano, Maria Teresa Voso. Biology (Basel) 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.
Patrick S Ward, Jay Patel, David R Wise, Omar Abdel-Wahab, Bryson D Bennett, Hilary A Coller, Justin R Cross, Valeria R Fantin, Cyrus V Hedvat, Alexander E Perl,[...]. Cancer Cell 2010
100

Rationale for Targeting Deregulated Metabolic Pathways as a Therapeutic Strategy in Acute Myeloid Leukemia.
Nicolas Chapuis, Laury Poulain, Rudy Birsen, Jerome Tamburini, Didier Bouscary. Front Oncol 2019
16
100

Nucleic acid oxidation in DNA damage repair and epigenetics.
Guanqun Zheng, Ye Fu, Chuan He. Chem Rev 2014
51
100

BH3-only proteins in apoptosis and beyond: an overview.
E Lomonosova, G Chinnadurai. Oncogene 2008
272
100

AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone Marrow.
Yusuke Saito, Richard H Chapple, Angelique Lin, Ayumi Kitano, Daisuke Nakada. Cell Stem Cell 2015
125
100

Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia.
Yihong Guan, Edward F Greenberg, Metis Hasipek, Shi Chen, Xiaochen Liu, Cassandra M Kerr, Daniel Gackowski, Ewelina Zarakowska, Tomas Radivoyevitch, Xiaorong Gu,[...]. Commun Biol 2020
10
100

The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia.
Nina Fenouille, Christopher F Bassil, Issam Ben-Sahra, Lina Benajiba, Gabriela Alexe, Azucena Ramos, Yana Pikman, Amy S Conway, Michael R Burgess, Qing Li,[...]. Nat Med 2017
40
100

Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer.
Ding Peng, Guangzhe Ge, Yanqing Gong, Yonghao Zhan, Shiming He, Bao Guan, Yifan Li, Ziying Xu, Han Hao, Zhisong He,[...]. Clin Epigenetics 2018
19
100

Mutations in AML: prognostic and therapeutic implications.
Courtney D DiNardo, Jorge E Cortes. Hematology Am Soc Hematol Educ Program 2016
62
100

ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair.
Claudia Cosentino, Domenico Grieco, Vincenzo Costanzo. EMBO J 2011
261
100

Metabolic requirements for the maintenance of self-renewing stem cells.
Keisuke Ito, Toshio Suda. Nat Rev Mol Cell Biol 2014
565
100

Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms.
Anna M Jankowska, Hadrian Szpurka, Ramon V Tiu, Hideki Makishima, Manuel Afable, Jungwon Huh, Christine L O'Keefe, Rebecca Ganetzky, Michael A McDevitt, Jaroslaw P Maciejewski. Blood 2009
286
100

Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification.
Shinsuke Ito, Ana C D'Alessio, Olena V Taranova, Kwonho Hong, Lawrence C Sowers, Yi Zhang. Nature 2010
100

Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA.
Yu-Fei He, Bin-Zhong Li, Zheng Li, Peng Liu, Yang Wang, Qingyu Tang, Jianping Ding, Yingying Jia, Zhangcheng Chen, Lin Li,[...]. Science 2011
100

Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms.
F Traina, V Visconte, P Elson, A Tabarroki, A M Jankowska, E Hasrouni, Y Sugimoto, H Szpurka, H Makishima, C L O'Keefe,[...]. Leukemia 2014
217
100

Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia.
Hassan Awada, Yasunobu Nagata, Abhinav Goyal, Mohammad F Asad, Bhumika Patel, Cassandra M Hirsch, Teodora Kuzmanovic, Yihong Guan, Bartlomiej P Przychodzen, Mai Aly,[...]. Blood Adv 2019
17
100

Enasidenib: First Global Approval.
Esther S Kim. Drugs 2017
61
100

TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23).
R B Lorsbach, J Moore, S Mathew, S C Raimondi, S T Mukatira, J R Downing. Leukemia 2003
293
100

Metabolic regulation of hematopoietic stem cells in the hypoxic niche.
Toshio Suda, Keiyo Takubo, Gregg L Semenza. Cell Stem Cell 2011
485
100

Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition.
James J Harding, Maeve A Lowery, Alan H Shih, Juan M Schvartzman, Shengqi Hou, Christopher Famulare, Minal Patel, Mikhail Roshal, Richard K Do, Ahmet Zehir,[...]. Cancer Discov 2018
63
100

Frequent pathway mutations of splicing machinery in myelodysplasia.
Kenichi Yoshida, Masashi Sanada, Yuichi Shiraishi, Daniel Nowak, Yasunobu Nagata, Ryo Yamamoto, Yusuke Sato, Aiko Sato-Otsubo, Ayana Kon, Masao Nagasaki,[...]. Nature 2011
100

From Bench to Bedside and Beyond: Therapeutic Scenario in Acute Myeloid Leukemia.
Carmelo Gurnari, Maria Teresa Voso, Jaroslaw P Maciejewski, Valeria Visconte. Cancers (Basel) 2020
6
100

Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival.
Hongying Yang, Tianle Yang, Joseph A Baur, Evelyn Perez, Takashi Matsui, Juan J Carmona, Dudley W Lamming, Nadja C Souza-Pinto, Vilhelm A Bohr, Anthony Rosenzweig,[...]. Cell 2007
688
100

Genomic Classification and Prognosis in Acute Myeloid Leukemia.
Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger, Verena I Gaidzik, Peter Paschka, Nicola D Roberts, Nicola E Potter, Michael Heuser, Felicitas Thol, Niccolo Bolli,[...]. N Engl J Med 2016
100

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias.
R Itzykson, O Kosmider, T Cluzeau, V Mansat-De Mas, F Dreyfus, O Beyne-Rauzy, B Quesnel, N Vey, V Gelsi-Boyer, S Raynaud,[...]. Leukemia 2011
350
100

DNA demethylation pathways: Additional players and regulators.
Matthias Bochtler, Agnieszka Kolano, Guo-Liang Xu. Bioessays 2017
75
100

Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cells.
Twee Tsao, Yuexi Shi, Steven Kornblau, Hongbo Lu, Sergej Konoplev, Ansu Antony, Vivian Ruvolo, Yi Hua Qiu, Ninaxiang Zhang, Kevin R Coombes,[...]. Ann Hematol 2012
76
100

Epigenetic Enzyme Mutations: Role in Tumorigenesis and Molecular Inhibitors.
Mei Han, Lina Jia, Wencai Lv, Lihui Wang, Wei Cui. Front Oncol 2019
27
100

TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells.
Lise Secardin, Cintia Elisabeth Gomez Limia, Antonio di Stefano, Martin Hernan Bonamino, Joseph Saliba, Keisuke Kataoka, Stevens K Rehen, Hana Raslova, Caroline Marty, Seishi Ogawa,[...]. Stem Cell Res 2020
3
100

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia.
Daniel A Pollyea, Brett M Stevens, Courtney L Jones, Amanda Winters, Shanshan Pei, Mohammad Minhajuddin, Angelo D'Alessandro, Rachel Culp-Hill, Kent A Riemondy, Austin E Gillen,[...]. Nat Med 2018
254
100

Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.
Nathalie Jacque, Anne Marie Ronchetti, Clément Larrue, Godelieve Meunier, Rudy Birsen, Lise Willems, Estelle Saland, Justine Decroocq, Thiago Trovati Maciel, Mireille Lambert,[...]. Blood 2015
198
100

TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.
Cyril Quivoron, Lucile Couronné, Véronique Della Valle, Cécile K Lopez, Isabelle Plo, Orianne Wagner-Ballon, Marcio Do Cruzeiro, Francois Delhommeau, Bertrand Arnulf, Marc-Henri Stern,[...]. Cancer Cell 2011
611
100

Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors.
Elodie Pronier, Carole Almire, Hayat Mokrani, Aparna Vasanthakumar, Audrey Simon, Barbara da Costa Reis Monte Mor, Aline Massé, Jean-Pierre Le Couédic, Frédéric Pendino, Bruno Carbonne,[...]. Blood 2011
128
100

Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.
Mengtao Xiao, Hui Yang, Wei Xu, Shenghong Ma, Huaipeng Lin, Honguang Zhu, Lixia Liu, Ying Liu, Chen Yang, Yanhui Xu,[...]. Genes Dev 2012
569
100

SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts.
V Visconte, H Makishima, A Jankowska, H Szpurka, F Traina, A Jerez, C O'Keefe, H J Rogers, M A Sekeres, J P Maciejewski,[...]. Leukemia 2012
166
100

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes.
T Haferlach, Y Nagata, V Grossmann, Y Okuno, U Bacher, G Nagae, S Schnittger, M Sanada, A Kon, T Alpermann,[...]. Leukemia 2014
880
100

Synergistic activity of IDH1 inhibitor BAY1436032 with azacitidine in IDH1 mutant acute myeloid leukemia.
Anuhar Chaturvedi, Charu Gupta, Razif Gabdoulline, Nora M Borchert, Ramya Goparaju, Stefan Kaulfuss, Kerstin Görlich, Renate Schottmann, Basem Othman, Julia Welzenbach,[...]. Haematologica 2021
9
100

Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia.
Mark A Gregory, Travis Nemkov, Julie A Reisz, Vadym Zaberezhnyy, Kirk C Hansen, Angelo D'Alessandro, James DeGregori. Exp Hematol 2018
38
100

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
Courtney D DiNardo, Eytan M Stein, Stéphane de Botton, Gail J Roboz, Jessica K Altman, Alice S Mims, Ronan Swords, Robert H Collins, Gabriel N Mannis, Daniel A Pollyea,[...]. N Engl J Med 2018
584
100

Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib.
Lynn Quek, Muriel D David, Alison Kennedy, Marlen Metzner, Michael Amatangelo, Alan Shih, Bilyana Stoilova, Cyril Quivoron, Maël Heiblig, Christophe Willekens,[...]. Nat Med 2018
81
100

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
Guido Marcucci, Kati Maharry, Yue-Zhong Wu, Michael D Radmacher, Krzysztof Mrózek, Dean Margeson, Kelsi B Holland, Susan P Whitman, Heiko Becker, Sebastian Schwind,[...]. J Clin Oncol 2010
537
100

Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1.
Andrew B Das, Purvi M Kakadia, Damian Wojcik, Lucy Pemberton, Peter J Browett, Stefan K Bohlander, Margreet C M Vissers. Blood Cancer J 2019
22
100

Venetoclax for AML: changing the treatment paradigm.
Daniel A Pollyea, Maria Amaya, Paolo Strati, Marina Y Konopleva. Blood Adv 2019
54
100

Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation.
Annalisa Roberti, Agustín F Fernández, Mario F Fraga. Mol Metab 2021
10
100

NAD and ADP-ribose metabolism in mitochondria.
Christian Dölle, Johannes G M Rack, Mathias Ziegler. FEBS J 2013
70
100

The role of α-ketoglutarate-dependent proteins in pluripotency acquisition and maintenance.
Khoa A Tran, Caleb M Dillingham, Rupa Sridharan. J Biol Chem 2019
14
100

A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid Neoplasms.
Yihong Guan, Anand D Tiwari, James G Phillips, Metis Hasipek, Dale R Grabowski, Simona Pagliuca, Priyanka Gopal, Cassandra M Kerr, Vera Adema, Tomas Radivoyevitch,[...]. Blood Cancer Discov 2021
6
100

How I treat acute myeloid leukemia in the era of new drugs.
Courtney D DiNardo, Andrew H Wei. Blood 2020
77
100

Acetylation Enhances TET2 Function in Protecting against Abnormal DNA Methylation during Oxidative Stress.
Yang W Zhang, Zhihong Wang, Wenbing Xie, Yi Cai, Limin Xia, Hariharan Easwaran, Jianjun Luo, Ray-Whay Chiu Yen, Yana Li, Stephen B Baylin. Mol Cell 2017
76
100

Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients.
Giacomo Coltro, Abhishek A Mangaonkar, Terra L Lasho, Christy M Finke, Prateek Pophali, Ryan Carr, Naseema Gangat, Moritz Binder, Animesh Pardanani, Martin Fernandez-Zapico,[...]. Leukemia 2020
30
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.